Clinical Trial Update: Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares the hyperemic efficacy of nicorandil and adenosine for measuring fractional flow reserve in patients with coronary artery d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Adenosine (Adenosine)
• Nicorandil (nicorandil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease, Myocardial Ischemia | Phase 4 | Status: UNKNOWN